Ausgabe 7/2010
Inhalt (22 Artikel)
Off-label use of rituximab in systemic lupus erythematosus: a systematic review
Eleanor Murray, Martin Perry
Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients
Dawei Hu, Xiaoqian Liu, Shunle Chen, Chunde Bao
Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab
Herwig Pieringer, Ulrike Stuby, Erich Pohanka, Georg Biesenbach
Renal disease in systemic sclerosis with normal serum creatinine
Reem H. A. Mohamed, Hania S. Zayed, Amr Amin
Osteoarthritis of the hip or knee: which coexisting disorders are disabling?
Kerstin G. Reeuwijk, Mariëtte de Rooij, Gabriella M. van Dijk, Cindy Veenhof, Martijn P. Steultjens, Joost Dekker
Validity, reliability, and comparison of the WOMAC osteoarthritis index and Lequesne algofunctional index in Turkish patients with hip or knee osteoarthritis
Sibel Basaran, Rengin Guzel, Gulsah Seydaoglu, Fusun Guler-Uysal
Juvenile idiopathic arthritis among Nigerians: a case study
Olufemi O. Adelowo, A. Umar
Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade
Ashit Syngle, Kanchan Vohra, Anjali Sharma, L. Kaur
The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
Meng-Yu Weng, Chia-Tse Weng, Ming-Fei Liu
Reinforcing a medical hypothesis with a new question: is there a subgroup of shrinking lungs syndrome that is induced by pleurisy in systemic lupus erythematosus and is this subgroup marked by anti-Ro/SSA?
Fabricio Souza Neves, Thais Helena Otto da Silva, Gislaine Paviani, Adriana Fontes Zimmermann, Glaucio Ricardo Werner de Castro, Ivânio Alves Pereira
Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis
Samira Rostom, Karima Benbouaaza, Bouchra Amine, Rachid Bahiri, Yousra Ibn Yacoub, Sanae Ali Ou Alla, Redouane Abouqal, Najia Hajjaj-Hassouni
Primary Sjogren’s syndrome with anticentromere antibodies—a clinically distinct subset
Dhiraj Gulati, Irving Kushner, Elizabeth File, Marina Magrey
The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis
Gleb Slobodin, Itzhak Rosner, Doron Rimar, Nina Boulman, Michael Rozenbaum, Majed Odeh
Diffuse systemic sclerosis and autoimmune hepatitis: a unique association
Carlos Ewerton Maia Rodrigues, Cláudia Lobato Borges, Jozélio Freire de Carvalho
Exertional paraspinal muscle rhabdomyolysis and compartment syndrome: a cause of back pain not to be missed
Lori Wik, Jeffrey M. Patterson, Anna E. Oswald
A case of Hughes–Stovin syndrome associated with hyperhomocysteinemia
Hyun-Ok Kim, Ho Cheol Kim, Yongwhi Park, Yong-Geun Jeong, Jae Hee Kim, Dae-Hong Jeon, Kyoung-Nyeo Jeon, Sang-Il Lee
An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis
Melinda Vincze, Peter A. Molnár, Judit Tumpek, Lászlóné Szőllősi, Ágnes Gyetvai, Anikó Kapitány, Katalin Dankó
Renal cortical necrosis at presentation in a patient with systemic lupus erythematosus: an autopsy case report
Megha S. Uppin, Liza Rajasekhar, H. Swetha, V. R. Srinivasan, Aruna K. Prayaga
Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?
Takao Nagashima, Seiji Minota
Erratum to: Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee
Karel Pavelka, Philippe Coste, Pál Géher, Gerhard Krejci